KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Encompass Health (EHC) EBIAT (2016 - 2026)

Encompass Health (EHC) has disclosed EBIAT for 18 consecutive years, with $248.2 million as the latest value for Q1 2026.

  • For Q1 2026, EBIAT rose 63.29% year-over-year to $248.2 million; the TTM value through Mar 2026 reached $855.9 million, up 83.79%, while the annual FY2025 figure was $760.1 million, 66.8% up from the prior year.
  • EBIAT hit $248.2 million in Q1 2026 for Encompass Health, down from $338.2 million in the prior quarter.
  • Across five years, EBIAT topped out at $338.2 million in Q4 2025 and bottomed at $20.1 million in Q4 2023.
  • Average EBIAT over 5 years is $124.6 million, with a median of $117.2 million recorded in 2023.
  • Year-over-year, EBIAT plummeted 82.89% in 2023 and then soared 1582.59% in 2025.
  • Encompass Health's EBIAT stood at $117.5 million in 2022, then tumbled by 82.89% to $20.1 million in 2023, then changed by 0.0% to $20.1 million in 2024, then skyrocketed by 1582.59% to $338.2 million in 2025, then fell by 26.61% to $248.2 million in 2026.
  • According to Business Quant data, EBIAT over the past three periods came in at $248.2 million, $338.2 million, and $126.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.